Volume 12, Issue 7, July 2010
Editorial
Journal to shift practice on obtaining conflict of interest declarations
Neuro-Oncology, Volume 12, Issue 7, July 2010, Pages 619–620, https://doi.org/10.1093/neuonc/noq064
Basic and Translational Investigations
Activating mutations in BRAF characterize a spectrum of pediatric low-grade gliomas
Neuro-Oncology, Volume 12, Issue 7, July 2010, Pages 621–630, https://doi.org/10.1093/neuonc/noq007
Systemic immune suppression in glioblastoma: the interplay between CD14+HLA-DRlo/neg monocytes, tumor factors, and dexamethasone
Neuro-Oncology, Volume 12, Issue 7, July 2010, Pages 631–644, https://doi.org/10.1093/neuonc/noq001
A 3-dimensional extracellular matrix as a delivery system for the transplantation of glioma-targeting neural stem/progenitor cells
Neuro-Oncology, Volume 12, Issue 7, July 2010, Pages 645–654, https://doi.org/10.1093/neuonc/noq002
Evaluation of retinoic acid therapy for OTX2-positive medulloblastomas
Neuro-Oncology, Volume 12, Issue 7, July 2010, Pages 655–663, https://doi.org/10.1093/neuonc/nop062
Distinct patterns of 1p and 19q alterations identify subtypes of human gliomas that have different prognoses
Neuro-Oncology, Volume 12, Issue 7, July 2010, Pages 664–678, https://doi.org/10.1093/neuonc/nop075
Analysis of specialized DNA polymerases expression in human gliomas: association with prognostic significance
Neuro-Oncology, Volume 12, Issue 7, July 2010, Pages 679–686, https://doi.org/10.1093/neuonc/nop074
Predominant antitumor effects by fully human anti-TRAIL-receptor2 (DR5) monoclonal antibodies in human glioma cells in vitro and in vivo
Neuro-Oncology, Volume 12, Issue 7, July 2010, Pages 687–700, https://doi.org/10.1093/neuonc/nop069
CX3CR1/CX3CL1 axis negatively controls glioma cell invasion and is modulated by transforming growth factor-beta1
Neuro-Oncology, Volume 12, Issue 7, July 2010, Pages 701–710, https://doi.org/10.1093/neuonc/nop076
CLINICAL INVESTIGATIONS
Adjuvant whole-brain radiation therapy after surgical resection of single brain metastases
Neuro-Oncology, Volume 12, Issue 7, July 2010, Pages 711–719, https://doi.org/10.1093/neuonc/noq005
Early complete response during chemotherapy predicts favorable outcome in patients with primary CNS lymphoma
Neuro-Oncology, Volume 12, Issue 7, July 2010, Pages 720–724, https://doi.org/10.1093/neuonc/noq010
Oncological patterns of care and outcome for 952 patients with newly diagnosed glioblastoma in 2004
Neuro-Oncology, Volume 12, Issue 7, July 2010, Pages 725–735, https://doi.org/10.1093/neuonc/noq030
High-dose methotrexate and rituximab with deferred radiotherapy for newly diagnosed primary B-cell CNS lymphoma
Neuro-Oncology, Volume 12, Issue 7, July 2010, Pages 736–744, https://doi.org/10.1093/neuonc/noq011
Rapid Reports
Oligodendroglioma cell lines containing t(1;19)(q10;p10)
Neuro-Oncology, Volume 12, Issue 7, July 2010, Pages 745–755, https://doi.org/10.1093/neuonc/noq031
Sensitivity to temozolomide in brain tumor initiating cells
Neuro-Oncology, Volume 12, Issue 7, July 2010, Pages 756–760, https://doi.org/10.1093/neuonc/noq032
Erratum
Erratum
Neuro-Oncology, Volume 12, Issue 7, July 2010, Page 761, https://doi.org/10.1093/neuonc/noq065
News and Announcements
Society news
Neuro-Oncology, Volume 12, Issue 7, July 2010, Page 762, https://doi.org/10.1093/neuonc/noq066
Cover/Standing Material
Cover Page
Neuro-Oncology, Volume 12, Issue 7, July 2010, Page NP, https://doi.org/10.1093/neuonc/noq067
Editorial Board
Neuro-Oncology, Volume 12, Issue 7, July 2010, Page NP, https://doi.org/10.1093/neuonc/noq068
Subscription Page
Neuro-Oncology, Volume 12, Issue 7, July 2010, Page NP, https://doi.org/10.1093/neuonc/noq069
